Puroindolines as fusion-protein carriers in molecular pharming

C - Chemistry – Metallurgy – 12 – P

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12P 21/00 (2006.01) C07K 1/14 (2006.01) C07K 19/00 (2006.01)

Patent

CA 2555137

Described are methods and compositions for producing proteinated granules and isolating desired products (for example, one or more protein, peptide, remediant, cosmeceutical, or pharmaceutical compound species) in transgenic plants engineered to produce the desired product(s). The present invention provides polynucleotide and polypeptide and protein sequences from plants to serve as carriers of recombinant fusion "cargo" proteins (also called "hybrid" or " multimeric" polypeptides), methods for targeting fusion polypeptides to starch granules, methods for tethering fusion polypeptides to the lipid layer associated with starch granule surfaces, and methods for using starch granule associated polypeptides as a carrier protein for the production of recombinant biopharmaceuticals. The desired products are isolated from the transgenic plants by size reduction (also called "milling") and air classification to remove the proteinated granule away from the endogenous host proteome.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Puroindolines as fusion-protein carriers in molecular pharming does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Puroindolines as fusion-protein carriers in molecular pharming, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Puroindolines as fusion-protein carriers in molecular pharming will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1615460

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.